Investor · 1 deal
Sydney, NSW
Every published round Taylor Collison took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Emyria | Unnamed stage | 1 May 2023 | $2.5m | Lead | Startup Daily, Tenmile portfolio |
Companies Taylor Collison has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Emyria | 1 May 2023 | 1 | 1 |
Fund closes reported for Taylor Collison, as distinct from the investments it has made.
Companies Taylor Collison has backed that another company then bought. An exit for the holding, not a deal Taylor Collison did.
Stories naming Taylor Collison. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Dataworks has begun seeking A$4.24 million through a placement and shareholder entitlement offer, with Cygnet Capital overseeing the process, and proceeds earmarked for debt repayment, working capital and delivery of government contracts.
Listed regtech firm Dataworks Group has locked in A$3 million in committed investor backing via a share placement, with Cygnet Capital running the raise, to repay debt and expand its government technology platforms.
Therapeutic psychedelics biotech Emyria has banked $2.5 million via a share placement co-led by Sixty Two Capital and Taylor Collison, with follow-on from Andrew Forrest's Tenmile, funding MDMA- and psilocybin-assisted therapy and cannabinoid trials.